BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
4423987
Number of visits today
1080
Number of downloads
4060642
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Omidkhah N, Ghodsi R. NO-HDAC dual inhibitors. Eur J Med Chem 2022;227:113934. [PMID: 34700268 DOI: 10.1016/j.ejmech.2021.113934] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Liang T, Wang F, Elhassan RM, Cheng Y, Tang X, Chen W, Fang H, Hou X. Targeting histone deacetylases for cancer therapy: Trends and challenges. Acta Pharmaceutica Sinica B 2023. [DOI: 10.1016/j.apsb.2023.02.007] [Reference Citation Analysis]
2 Omidkhah N, Hadizadeh F, Zarghi A, Ghodsi R. Synthesis, cytotoxicity, Pan-HDAC inhibitory activity and docking study of new N-(2-aminophenyl)-2-methylquinoline-4-carboxamide and (E)-N-(2-aminophenyl)-2-styrylquinoline-4-carboxamide derivatives as anticancer agents. Med Chem Res 2023. [DOI: 10.1007/s00044-023-03018-w] [Reference Citation Analysis]
3 Omidkhah N, Hadizadeh F, Abnous K, Ghodsi R. Synthesis, structure activity relationship and biological evaluation of a novel series of quinoline–based benzamide derivatives as anticancer agents and histone deacetylase (HDAC) inhibitors. Journal of Molecular Structure 2022;1267:133599. [DOI: 10.1016/j.molstruc.2022.133599] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345